Biogen announces phase 2 data for cutaneous lupus erythematosus
The results for litifilimab support the potential to achieve rapid and durable improvements in skin disease activity
- News
- Research
- Sales
- Regulatory
- Healthcare
- Marketing
Biogen announces phase 2 data for cutaneous lupus erythematosus
The results for litifilimab support the potential to achieve rapid and durable improvements in skin disease activity
Shionogi to acquire IntraBio in deal worth $2bn
The deal will expand Shionogi’s growing portfolio with IntraBio’s rare diseases capabilities
Roche’s fenebrutinib receives FDA filing acceptance for relapsing and primary progressive MS
If approved, this treatment would offer a new option for the nearly one million Americans living with MS
Chiesi UK and Ireland supports NHS workforce to address COPD diagnosis backlog
An estimated two million people in the UK are living with undiagnosed chronic obstructive pulmonary disease
CPHI Milan introduces new specialist zones
The event runs from 6-8 October 2026 at the Fiera Milano exhibition centre in Rho, Italy
Latest content
Avalere Health appoints Wendy Jory as Senior Vice President, Market Access
Jory was most recently Medicine Commercialization Lead, Product and Portfolio Strategy at GSK
Read More
Beam Therapeutics appoints Eric Foster as Chief Commercial Officer
Foster previously held senior roles at Ardelyx, Amgen, Horizon and GlaxoSmithKline
Read More
Nuclera appoints Carl Raimond as CEO
Co-founder and former CEO Michael Chen transitions to Chief Scientific and Business Officer
Read More
Inizio Evoke appoints Barbara Patchefsky as Global Client Lead
Patchefsky most recently served as Global Client Director at Havas Health & You
Read More
Intelligence
Strengthening engagement with HCPs needs deep understanding not digital bombardment
Closing the critical gap between HCPs’ need for information and the pharma industry’s ability to deliver relevant, tailored content
Read More
Cell and gene therapies – moving from niche innovations towards broader clinical use
Looking at the regulatory challenges of cell and gene therapies for serious or life-threatening rare diseases
Read More
Creating a strong patent portfolio through constant communication
Why patenting should not stop at the drug candidate stage – and why coordination between researchers and attorneys is essential for strong protection
Read More
Leading through complexity
Strengthening strategic judgement during uncertainty – exploring the strategic concepts that matter most
Read More
The Amazon reckoning: GLP-1s and the consumer lifestyle shift – why the molecule is no longer enough
Amazon’s entry into the GLP-1 market should be a signal to pharma that it needs to shift focus from molecule to ‘Operating Model’
Read More
Lupus – moving patient care beyond current therapies towards resetting the immune system
Precision medicine is no longer theoretical, but increasingly achievable for people living with lupus
Read More
Blogs
Latest
Rethinking Prenatal Migraine Management: The Clinical Case for Neuromodulation
October 8, 2026 | Medscape Education|
Disclaimer: Management of migraine in pregnancy typically combines lifestyle strategies, nonpharmacologic approaches, selected pharmacologic options when benefits outweigh risks, and, increasingly, noninvasive neuromodulation technologies.
Advancing the Frontier of Cancer Care: Medscape’s Mission at ESMO 2026
October 5, 2026 | Medscape Education|
For more than 30 years, Medscape Education’s dedication has been centered on a single goal: building independent, accredited oncology education that improves patient outcomes. This …
Join Genesis Research Group’s October webinar: ‘From scoping to systematic: Choosing the right literature review for your evidence needs’.
October 2, 2026 | Genesis Research Group|HEOR, TLR, evidence synthesis, literature review, slr
On Tuesday, 6 October 2026, Genesis Research Group’s evidence synthesis, HEOR, and evidence planning teams will be presenting an expert webinar on the topic of …
Using AI Responsibly in CME Outcomes Reporting
October 1, 2026 | Medscape Education|
ICYMI at #AIS2026: using AI in outcomes reporting is a lot like onboarding a research assistant. There’s real efficiency in having the help, and a …
ANTHEM launches Healthy Influence – a new science-led approach to solve healthcare’s attention problem
October 1, 2026 | Resonant Group|Behavioural science, Healthcare PR, healthcare communications
Global healthcare communications consultancy ANTHEM, a Resonant Group company, today announces the launch of Healthy Influence™, its proprietary methodology that applies the science of influence …
Pharma leadership strategies for talent, AI adoption, and continuous learning
October 8, 2026 | Inizio|AI, Digital, Pharma, healthcare
In a recent interview with Pharma Exec, Elaine Ferguson, Global President of Inizio Medical, explores how pharma leadership can support talent development, use AI to …
Invited, but not equipped: patient involvement needs more than an open door
October 8, 2026 | Cuttsy + Cuttsy|EU HTA, Joint Clinical Assessment, Joint Scientific Assessment, clinical trials
Explore how pharma can help patients and patient organisations prepare for meaningful involvement in EU HTA without shaping their contribution.
The outcomes are already chosen. So when can patients really shape them?
September 29, 2026 | Cuttsy + Cuttsy|Clinical assessment, EU HTA, Joint Clinical Assessment, Joint Scientific Consultation, clinical trial
Explore why involving patients early in Joint Scientific Consultations is critical to shaping the outcomes measured in clinical trials.
The partnership paradox in pharma: Why the best client–agency relationships feel less like business
September 29, 2026 | Emotive|
In MedComms, great client–agency partnerships go far beyond delivering what’s requested, when it’s needed. At their best, they’re built on something deeper – an ambition …
Long-term clinical trial engagement is a behavioural challenge – not just an informational one
September 24, 2026 | Cuttsy + Cuttsy|Behavioural science, Engagement, clinical study, clinical trials, communication, empathy, experience, retention
Explore why long-term clinical trial engagement is a behavioural challenge, showing how proactive support from site teams can help participants stay connected, confident and committed …